Cargando…

Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson’s Disease

INTRODUCTION: Neuroinflammation may play as an important risk factor in progressive degeneration of dopaminergic cells. Antioxidants have protective effects against free radicals-induced neural damage in Parkinson’s disease (PD). In the present study, we examined the effects of ellagic acid (EA) on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farbood, Yaghoob, Sarkaki, Alireza, Dolatshahi, Mojtaba, Taqhi Mansouri, Seyed Mohammad, Khodadadi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Neuroscience Society 2015
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636882/ https://www.ncbi.nlm.nih.gov/pubmed/27307952

Ejemplares similares

Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson’s disease
por: Dolatshahi, Mojtaba, et al.
Publicado: (2015)

Ellagic acid attenuates post-cerebral ischemia and reperfusion behavioral deficits by decreasing brain tissue inflammation in rats
por: Hassonizadeh Falahieh, Khadijeh, et al.
Publicado: (2020)

Therapeutic effects of ellagic acid on memory, hippocampus electrophysiology deficits, and elevated TNF-α level in brain due to experimental traumatic brain injury
por: Mashhadizadeh, Shahram, et al.
Publicado: (2017)

Ellagic Acid Protects Cardiac Arrhythmias Following Global Cerebral Ischemia/Reperfusion Model
por: Dianat, Mahin, et al.
Publicado: (2019)

The effects of gallic acid on pain and memory following transient global ischemia/reperfusion in Wistar rats
por: Farbood, Yaghoob, et al.
Publicado: (2013)

Ellagic acid improves electrocardiogram waves and blood pressure against global cerebral ischemia rat experimental models
por: Nejad, Khojasteh Hoseiny, et al.
Publicado: (2015)

The effects of betulinic acid chronic administration on the motor, non-motor behaviors, and globus pallidus local field potential power in a rat model of hemiparkinsonism
por: Abrishamdar, Maryam, et al.
Publicado: (2022)

Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
por: Ghalami, Jamileh, et al.
Publicado: (2021)

Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats
por: Moradi Vastegani, Sadegh, et al.
Publicado: (2023)

Effect of Berberine against Cognitive Deficits in Rat Model of Thioacetamide-Induced Liver Cirrhosis and Hepatic Encephalopathy (Behavioral, Biochemical, Molecular and Histological Evaluations)
por: Hajipour, Somayeh, et al.
Publicado: (2023)

Synaptic plasticity and cognitive impairment consequences to acute kidney injury: Protective role of ellagic acid
por: Sarkaki, Alireza, et al.
Publicado: (2022)

Effects of ellagic acid pretreatment on renal functions disturbances induced by global cerebral ischemic-reperfusion in rat
por: Nejad, Khojasteh Hoseiny, et al.
Publicado: (2017)

Sesamin alleviates defects in seizure, behavioral symptoms, and hippocampus electroencephalogram in a pentylenetetrazol rat model
por: Malekinia, Farima, et al.
Publicado: (2023)

Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease
por: Jalali, Maryam Sadat, et al.
Publicado: (2021)

Thymoquinone improves cognitive and hippocampal long-term potentiation deficits due to hepatic encephalopathy in rats
por: Hajipour, Somayeh, et al.
Publicado: (2021)

Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats
por: Khombi Shooshtari, Maryam, et al.
Publicado: (2021)

Effect of Gallic Acid on Dementia Type of Alzheimer Disease in Rats: Electrophysiological and Histological Studies
por: Hajipour, Somayeh, et al.
Publicado: (2016)

Effects of fresh, aged and cooked garlic extracts on short- and long-term memory in diabetic rats
por: Sarkaki, Alireza, et al.
Publicado: (2013)

Improvement in Memory and Brain Long-term Potentiation Deficits Due to Permanent Hypoperfusion/Ischemia by Grape Seed Extract in Rats
por: Sarkaki, Alireza, et al.
Publicado: (2013)

Effects of Venlafaxine & Methadone Alone and in Combination with Spontaneous Morphine withdrawal Syndrome & Pain Sensation in Rats
por: Fadaei-Kenarsary, Meisam, et al.
Publicado: (2015)

Motor disturbances and thalamic electrical power of frequency bands' improve by grape seed extract in animal model of Parkinson's disease
por: Sarkaki, Alireza, et al.
Publicado: (2012)

Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson’s Disease
por: Stayte, Sandy, et al.
Publicado: (2015)

Ellagic acid improved arrhythmias induced by CaCL(2) in the rat stress model
por: Dianat, Mahin, et al.
Publicado: (2015)

Chronic Spinal Cord Electrical Stimulation Protects Against 6-hydroxydopamine Lesions
por: Yadav, Amol P., et al.
Publicado: (2014)

The 1-Tosylpentan-3-one Protects against 6-Hydroxydopamine-Induced Neurotoxicity
por: Kao, Chien-Jen, et al.
Publicado: (2017)

Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
por: De Jesús-Cortés, Héctor, et al.
Publicado: (2015)

Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease via inhibiting oxidative stress
por: Nourmohammadi, Saeideh, et al.
Publicado: (2022)

Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies
por: Mirshekar, Mohammad Ali, et al.
Publicado: (2018)

p-Coumaric acid has pure anti-inflammatory characteristics against hepatopathy caused by ischemia-reperfusion in the liver and dust exposure
por: Moradi, Mojtaba, et al.
Publicado: (2023)

Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinson's Disease
por: Galindo, Maria F., et al.
Publicado: (2012)

Parkinson’s Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model
por: Silva da Fonsêca, Victor, et al.
Publicado: (2023)

Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson’s disease related toxin 6-hydroxydopamine
por: Chierchia, Armando, et al.
Publicado: (2017)

Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson’s Disease in Rats
por: Tiwari, Prafulla Chandra, et al.
Publicado: (2021)

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease; Possible Involvement of Dopaminergic Neurotransmission
por: Vajdi-Hokmabad, Reza, et al.
Publicado: (2017)

Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson’s Disease
por: Ardah, Mustafa T., et al.
Publicado: (2020)

Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra
por: Nadella, Rasajna, et al.
Publicado: (2014)

Cortex Fraxini (Qingpi) Protects Rat Pheochromocytoma Cells against 6-Hydroxydopamine-Induced Apoptosis
por: Li, Jing-Jie, et al.
Publicado: (2015)

Protective Effect of Amber Extract on Human Dopaminergic Cells against 6-Hydroxydopamine-Induced Neurotoxicity
por: Luo, Yuening, et al.
Publicado: (2022)

Lesioning of the Striatum Reverses Motor Asymmetry in the 6-Hydroxydopamine Rodent Model of Parkinsonism
por: Friehs, G. M., et al.
Publicado: (1991)

Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
por: Pišlar, Anja, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_68rsuhd82b1vnfstms92vpv5op